Search results for “Immune thrombocytopenia” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 197 patents, we discovered top 41 key players by total patent application. Principia Biopharma, Inc., AB Biosciences, Inc., Genentech, Inc. are dominant in this area. They take 23.86% of the total patent filing.
Principia Biopharma, Inc.
California, United States
Patent: 18
AB Biosciences, Inc.
Massachusetts, United States
Patent: 16
Genentech, Inc.
California, United States
Patent: 13
Annexon, Inc.
California, United States
Patent: 11
Novartis AG
Basel-Stadt, Switzerland
Patent: 10
Bristol Myers Squibb Co.
New York, United States
Patent: 10
UCB Biopharma SRL
Belgium
Patent: 10
Synthon BV
Gelderland, Netherlands
Patent: 8
Lunan Pharmaceutical Group Co., Ltd.
Shandong Sheng, China
Patent: 8
Shanghai Kexin Biotech Co., Ltd.
Shanghai Shi, China
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 5 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Ractigen Therapeutics
Jiangsu Sheng, China
Patent: 5
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 137 patents applied in the last 5 years. We discover 34 most active companies in this area. The fast-growing Principia Biopharma, Inc., Annexon, Inc., Novartis AG take 28.47% of patent filing during this period.
Principia Biopharma, Inc.
California, United States
Patent: 18
Annexon, Inc.
California, United States
Patent: 11
Novartis AG
Basel-Stadt, Switzerland
Patent: 10
UCB Biopharma SRL
Belgium
Patent: 8
Synthon BV
Gelderland, Netherlands
Patent: 8
STARTUP
Ractigen Therapeutics
Jiangsu Sheng, China
Patent: 5
AB Biosciences, Inc.
Massachusetts, United States
Patent: 4
UCB Pharma SA
Spain
Patent: 3
Peking University People's Hospital
China
Patent: 3
Bio-Thera Solutions, Ltd.
Guangdong Sheng, China
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 137 patents in last 5 years, we discover 28 new entrants. Principia Biopharma, Inc., Annexon, Inc., Novartis AG are the most active new entrants in this area.
Principia Biopharma, Inc.
California, United States
Patent: 18
Annexon, Inc.
California, United States
Patent: 11
Novartis AG
Basel-Stadt, Switzerland
Patent: 10
Synthon BV
Gelderland, Netherlands
Patent: 8
STARTUP
Ractigen Therapeutics
Jiangsu Sheng, China
Patent: 5
Peking University People's Hospital
China
Patent: 3
Bio-Thera Solutions, Ltd.
Guangdong Sheng, China
Patent: 3
Novartis Pharmaceuticals Corp.
New Jersey, United States
Patent: 2
Soochow University
Jiangsu Sheng, China
Patent: 2
Daegu Gyeongbuk Institute of Science & Technology
South Korea
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 18 patents, we discovered top 5 universities and scientific research institutions by total patent application. Soochow University, Jilin University, The University of Newcastle are dominant in this area. They take 27.78% of the total patent filing.
Soochow University
Jiangsu Sheng, China
Patent: 2
Jilin University
Jilin Sheng, China
Patent: 1
The University of Newcastle
New South Wales, Australia
Patent: 1
Chengdu University of Traditional Chinese Medicine
Sichuan Sheng, China
Patent: 1
Shanghai University of Traditional Chinese Medicine
Shanghai Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: